Mundipharma
Edward Jose is a seasoned finance and data analyst with extensive experience in system analysis, data extraction, and reporting across multiple industries, including pharmaceuticals, telecommunications, and travel. Currently serving as a Finance Systems Analyst at Mundipharma, Edward is responsible for enhancing the group consolidation system, managing user acceptance testing, and providing valuable training to global finance teams. Prior experience includes working at Virgin Media O2 as an Insight Analyst, where Edward generated insights to drive compliance and cost reductions, and holding various roles at Travelport, where expertise in SQL and data visualization was developed. Edward also led data reporting teams at infinite Field Marketing and provided market insights at WHSmith, showcasing a solid foundation in data analysis and project management. Edward holds a Bachelor of Arts degree in Geography from the University of the West of England.
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.